GFREE BIO, LLC

Biotech · Private

Automated algorithm software for fitting ligand binding regions in protein-ligand crystal structures using polar sampling, optimization, and electron density data

Grants
$225K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Polar sampling and optimization of protein-ligand cocrystal structures$224,934
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1492ProtaBody, Inc.—$800
1493SynPhaGen, LLC——
1494MITOSENSE, INC.—$2.2M
1495GFREE BIO, LLC——
1496BEXION PHARMACEUTICALS, INC.——
1497Viewpoint Therapeutics, Inc.—$25M
1498Enzyme by Design Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.